UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050665
Receipt number R000057723
Scientific Title A STUDY TO ASSESS THE EFFECT OF PRETREATMENT WITH INTRAVENOUS PALONOSETRON IN PREVENTING PAIN ON PROPOFOL INJECTION
Date of disclosure of the study information 2023/03/23
Last modified on 2023/03/23 23:31:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to assess the effect of palonosetron in preventing propofol pain

Acronym

A study to evaluate the effect of palonosetron in preventing propofol pain

Scientific Title

A STUDY TO ASSESS THE EFFECT OF PRETREATMENT WITH INTRAVENOUS PALONOSETRON IN PREVENTING PAIN ON PROPOFOL INJECTION

Scientific Title:Acronym

A study to evaluate effect of intravenous palonosetron in preventing pain on propofol injection

Region

Asia(except Japan)


Condition

Condition

ASA 1 and ASA 2 patients

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the effect of pre-treatment with intravenous palonosetron in preventing pain on propofol injection.
To evaluate the safety profile associated with the use of Palonosetron.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To assess the effect of pre-treatment with intravenous palonosetron in preventing pain on propofol injection.

Key secondary outcomes

To evaluate the safety profile associated with the use of Palonosetron.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Group P - received palonosetron 0.075mg (2ml) intravenous route before propofol injection

Interventions/Control_2

Group S - received normal saline (2ml) intravenous route

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

Patient who give written informed consent.
Patients aged 18-60 yrs.
Patients scheduled for elective surgery under general anaesthesia.
Patients with ASA (American Society of Anaesthesiologists) grade I & II

Key exclusion criteria

Patients refusing to participate in the study.
Patients inability to verbally express the severity of pain.
Patients with ischemic heart disease, previous myocardial infarction, congestive heart failure, congenital long QT syndrome.
Patients with electrolyte abnormalities.
Patients with hepatic and renal dysfunction.
Patients with chronic alcohol abuse and patients on antipsychotic drugs

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Nethra
Middle name
Last name S S

Organization

Bangalore Medical College and Research Institute

Division name

Department of Anaesthesiology

Zip code

560002

Address

Fort, K.R. Road Bangalore - 560 002 Karnataka, India

TEL

08026700810

Email

nethra.surhonne@gmail.com


Public contact

Name of contact person

1st name Chaithali
Middle name
Last name Hebri

Organization

Rajarajeswari Medical College and Hospital

Division name

Department of Anaesthesiology

Zip code

560074

Address

No.202, Kambipura, Mysore Road, Bengaluru-560 074.

TEL

7975454808

Homepage URL


Email

chaithali.hebri@gmail.com


Sponsor or person

Institute

Bangalore Medical College and Research Institute

Institute

Department

Personal name



Funding Source

Organization

NA

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Bangalore Medical College and Research Institute

Address

Fort, K.R. Road Bangalore - 560 002 Karnataka, India

Tel

08026700810

Email

chaithali.hebri@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 03 Month 23 Day


Related information

URL releasing protocol

will be entered later

Publication of results

Unpublished


Result

URL related to results and publications

will be entered later

Number of participants that the trial has enrolled

100

Results

100 patients.

Results date posted

2023 Year 03 Month 23 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Demographic characteristics, duration of surgery and the type of surgeries in both groups were comparable

Participant flow

100 patients of either sex were randomly allocated (computer generated randomisation) to two different groups of 50 each as described below
Group P received palonosetron 0.075mg (2ml) intravenous route
Group S received normal saline (2ml) intravenous route

Adverse events

QTc interval ,tinnitus was monitored.

Outcome measures

Assessment for degree of pain using McCrirrick and Hunter Pain Scale for propofol injection in both groups.
QTc interval will be monitored before premedication, pre-treatment after induction and then every half hrly till the end of the surgery

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 11 Month 01 Day

Date of IRB

2015 Year 11 Month 16 Day

Anticipated trial start date

2015 Year 11 Month 21 Day

Last follow-up date

2017 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 03 Month 23 Day

Last modified on

2023 Year 03 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057723


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name